Media Coverage Archives - NFCR

Media Coverage

New antibody therapy shows promising results for advanced, treatment-refractory pediatric brain cancer

Effective and safe treatments are needed for medulloblastoma—the most common type of cancerous brain tumor in children—especially for patients whose cancer has spread to the spinal cord. A recent phase I clinical trial led by researchers at Atrium Health Levine Children’s Hospital and Massachusetts General Hospital (MGH) has generated promising…...

Read more

A Closer Look at Glioblastoma and New Reasons for Hope

Approximately 15,000 Americans will be diagnosed with glioblastoma this year. Although considered a rare cancer, doctors are seeing an increase in cases of the aggressive and deadly brain cancer that’s notoriously hard to treat. A local organization that’s helping enroll brain cancer patients in clinical trials around the world gives…...

Read more

After Nearly 4 Decades of Research, W.K. Alfred Yung, MD, Sees a New Era Ahead for Advances in Brain Tumors

After he was not accepted into the University of Hong Kong, plan B for W.K. Alfred Yung, MD, was to leave his country and immigrate to the United States to attend the University of Minnesota in Minneapolis—a move he considers more exile than choice. Born on April 8, 1948, in…...

Read more

Using rooom to Build a Community

Together with the National Foundation for Cancer Research (NFCR) and the AIM-HI Accelerator Fund (AIM-HI) we hosted a charitable hybrid combo event on October 30 2021 – our first big project in the United States. While the live event took place at the National Press Club in Washington, D.C., virtual participation was…...

Read more

Cancer Drug Design Company Associated with Longtime NFCR Support Attracts New Investment

Rasio Therapeutics, a company whose cancer drug research technology was developed and applied in part with funding provided over many years by the National Foundation for Cancer Research to University of Maryland, Baltimore, researcher Curt Civin, has raised additional investment funding....

Read more

NFCR CMO Brian Leyland-Jones Featured in Pancreatic Cancer Risk Overview

Insights from National Foundation for Cancer Research Chief Medical Officer Brian Leyland-Jones, along with such other authoritative sources as Johns Hopkins Medicine, the Mayo Clinic and the U.S. National Cancer Institute, are featured in this Eat This, Not That! overview of pancreatic cancer warning signs....

Read more

Interview with NFCR CEO Sujuan Ba Featured in BioBuzz—a Popular Regional Industry News Source

5 Questions With…” is a weekly BioBuzz series where interesting people share a little about themselves, their work and maybe something completely unrelated. This week the series features Dr. Sujuan Ba, president and chief executive officer of the National Foundation for Cancer Research....

Read more

Daniel D. Von Hoff, MD, FACP, FASCO, FAACR, To Receive Inaugural AACR Scientific Achievement Award Established in His Honor

PHILADELPHIA – The American Association for Cancer Research (AACR) announced today that Daniel D. Von Hoff, MD, FACP, FASCO, FAACR, will receive the inaugural AACR Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research. Von Hoff is being recognized for his groundbreaking accomplishments as…...

Read more

Understanding the Role of Physical Traits of Cancer on Tumor Growth

To better understand tumor initiation and growth, National Foundation for Cancer Research (NFCR) Fellow Dr. Rakesh Jain and colleagues continue to investigate the role of the physical microenvironment surrounding cancer cells. When a tumor is growing, the tissues that surround the tumor are disrupted physically and biochemically. The outcomes of…...

Read more